Moderna Stock Jumps 12% as Wolfe Sees $9.2 Billion Intismeran Opportunity
Moderna shares jumped 12.2% on Tuesday after Wolfe Research abandoned its bearish rating. The move extended a volatile repricing of the vaccine maker's cancer pipeline.
Investor Dashboard
Mateusz Kaczmarek is a financial and technology journalist at TS2.tech. His coverage ranges from stocks and artificial intelligence to semiconductors and developments across global markets. He graduated from the Poznań University of Economics and Business and worked in financial analysis before becoming a business journalist. Follow Mateusz Kaczmarek on Google News.
